Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
Lung
Study Phase
Phase 2B
Study Completion Date
2007
NCT00453154Uploaded 10-23-2017
Available for Download
PDS UID: LungSm_Allianc_2007_218
N/A
Provider Information
Provider Data DescriptionPhase IB: To determine the phase II dose for sunitinib combined with cisplatin and etoposide. Phase II: To compare the progression-free survival of patients with extensive stage small cell lung cancer treated with cisplatin or carboplatin and etoposide followed by maintenance sunitinib to patients receiving the same chemotherapy followed by placebo. See protocol for further details.
SponsorAlliance for Clinical Trials in Oncology
Data ProviderAlliance for Clinical Trials in Oncology
Partial set or SubsetOriginal Data
Patients in dataset144
# of Patients Control46
# of Patients Experimental49
DOIhttps://doi.org/10.34949/zbwg-ef42
CDISC StandardADS
Study ArmsBoth comparator and experimental arm data
Clinical Trials.gov Information
Brief SummaryN/A
ConditionsN/A
Intervention TypePlacebo, Chemotherapy, Drug
Drug(s)N/A
Total EnrolledN/A
RandomizationN/A
Blinding MethodN/A
Arms InterventionN/A
Secondary IDN/A
PubMed (PMID)N/A
Collaborator(s)N/A
Region(s)N/A
Age RangeN/A
Files:
PROTOCOLC30504-13.pdf
CRFC30504-Allforms.pdf
DATA DICTIONARYc30504_dd.docx
DATA (BOTH COMPARATOR AND ACTIVE ARMS)ae.csv
DATA (BOTH COMPARATOR AND ACTIVE ARMS)clinical.csv
© 2023 Project Data Sphere
All rights reserved
Privacy PolicyTerms of Use